A treatment first used more than a century ago, that uses bacteria-killing viruses, is making a comeback in Australia and doctors hope it will help counter a growing crisis of antibiotic-resistant superbugs.
The Alfred hospital in Melbourne has become the first health service in Victoria to begin using the pioneering phage therapy, which involves utilising harmless viruses – known as bacteriophages – to kill germs in cases where traditional antibiotics have failed.
Professor Anton Peleg, head of infectious diseases at The Alfred, said phage therapy was being used for an increasing number of patients battling potentially deadly superbugs, on compassionate grounds.
“They are patients with severe bacterial infections that are either life-threatening, or limb threatening, or function threatening, where they don’t have any other options left,” Peleg said. “It is a salvage treatment pathway.”
However, global interest in the therapy was reawakened recently by the rise of superbugs that have developed a resistance to antibiotics.
“We desperately need novel approaches to attack superbugs, approaches that are different to existing traditional antibiotics,” Peleg said.
Increasingly, phages are now being seen by some scientists as a potential complement or even an alternative to antibiotics, the overuse of which has contributed to increasing bacterial resistance and the advent of the superbug.
The Alfred’s phage therapy program began at the end of last year in partnership with Monash University’s Centre to Impact AMR (antimicrobial resistance), and has already been used to treat people who are severely ill with antibiotic-resistant infections, including patients with cystic fibrosis, who have endured years of chronic lung infections.
Others being referred to the program include those with drug-resistant prosthetic joint or limb infections and severe burn wounds.
“We recently received another referral for a woman with a recurrent urinary tract infection with terribly resistant bacteria,” Peleg said.
According to the World Health Organisation, antimicrobial resistance is a rising threat to global health, jeopardising decades of medical progress and transforming common infections into deadly ones. A UN report suggests yearly deaths from drug-resistant diseases could rise from 700,000 to 10 million in 30 years if no action is taken.
Phage therapy, which is most commonly provided intravenously, can be required for several months. Peleg said patients at The Alfred undergoing the treatment were monitored closely to evaluate the activity of the phage in their bodies.
Peleg said the treatment depended on accurate diagnosis of the bacterial strain causing infection and the phage required to fight it. With billions of different bacteria killing viruses in our natural environment – found in river systems, soil and sewage – sourcing the appropriate phage can be difficult.
To speed up this process, Peleg and his team spent the past four years collecting the most common bacteria that have caused infections at The Alfred. Among them is Staphylococcus aureus bacteria, also known as golden staph and pseudomonas.
The hospital also has an onsite translational phage lab, where staff scour environmental sources, identify phages, then test their activity with a combination of antibiotics. The phages are then produced and packaged into vials by an expert team at Monash University.
“We’ve been storing the most common bacteria causing infection at The Alfred and are looking for phage that have killing activity against those bacteria to develop a phage biobank,” Peleg said. “This allows us to have a cocktail of multiple phages, prepared to use for future patients with bacterial infections.”
He said phage therapy was gaining traction in Australia, with teams in Melbourne and Western Australia treating their first patients recently.
But Iredell said a lack of robust data and large-scale clinical studies had hindered advancements and understanding. In Australia, the treatment is still deemed experimental and is awaiting approval by the Therapeutics Goods Administration.
“It’s our job to be sceptical, and we have to make sure this is safe, but all the data suggests so far that it is safe when it is used properly and the phage is made properly,” Iredell said.
Australians wanting the treatment must fit strict eligibility criteria, including being referred to an infectious disease specialist, who can certify they are already using the appropriate treatment and more was needed.
Iredell and Peleg are part of a group of doctors working to develop a regulatory framework to use phage therapy nationally in the hope it will pave the way for big clinical studies in Australian hospitals.
Experimental cases overseas, including two patients in the US who recovered from intractable infections after being treated with genetically engineered bacteria-killing viruses.
In 2019, a teenager in the UK also made a remarkable recovery after being among the first patients in the world to be given a genetically engineered virus to treat a drug-resistant infection.
“All of us in the phage community often joke for every bacterial problem there is a phage solution because they’re the natural predators and since before humans evolved,” Iredell said. “Antibiotic resistant infections are one of the greatest risks to modern health infrastructure, and we need to act now.”
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
